| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |